Immune modulation
Showing 1 - 25 of >10,000
Actinic Keratosis, Photodynamic Therapy Trial in Fairborn (Celecoxib 200mg, Placebo)
Recruiting
- Actinic Keratosis
- Photodynamic Therapy
- Celecoxib 200mg
- Placebo
-
Fairborn, OhioWright State Physicians
Mar 15, 2022
Reduction of Peanut Reactivity and Immune Modulation With
Recruiting
- Peanut Allergy
-
New York, New YorkDepartment of Genetic Medicine, Weill Cornell Medicine
Feb 23, 2022
COVID-19, Critical Illness, Hypercytokinemia Trial in Ulm (Application of exosomes in a whole blood assay)
Recruiting
- COVID-19
- +3 more
- Application of exosomes in a whole blood assay
-
Ulm, GermanyUlm University Hospital, Clinic of Anesthesiology and Intensive
Jan 17, 2022
Colon Cancer Trial in Boston (AMR101 (VASCEPA, icosapent ethyl))
Withdrawn
- Colon Cancer
- AMR101 (VASCEPA, icosapent ethyl)
-
Boston, MassachusettsMassachusetts General Hospital
Nov 10, 2021
Surgery, Immune System and Related Disorders, Preoperative Care Trial in Stanford (Physical Prehabilitation, Stress Reduction
Recruiting
- Surgery
- +6 more
- Physical Prehabilitation
- +3 more
-
Stanford, CaliforniaStanford University
Nov 26, 2021
Atopic Dermatitis Trial in Berlin (not applicable, observational study)
Recruiting
- Atopic Dermatitis
- not applicable, observational study
-
Berlin, GermanyDpt of Dermatology and Allergology, Charité - Universitätsmedizi
Oct 20, 2021
Hepatocellular Cancer, Gastrointestinal Cancer, Immunosuppression Trial in Taipei (Modern acupuncture)
Completed
- Hepatocellular Cancer
- +2 more
- Modern acupuncture
-
Taipei, TaiwanWanFangH
Dec 29, 2020
Metastatic Melanoma Trial in Pierre-Bénite (Blood and biopsy sampling)
Completed
- Metastatic Melanoma
- Blood and biopsy sampling
-
Pierre-Bénite, FranceService de Dermatologie, Centre Hospitalier Lyon Sud (HCL)
Dec 23, 2021
Allergic Rhinitis Trial in Taoyuan (Shin-yi-san + Xiao-qing-long-tang + Xiang-sha-liu-jun-zi-tang by the weight of 9g+3g+3g/day)
Completed
- Allergic Rhinitis
- Shin-yi-san + Xiao-qing-long-tang + Xiang-sha-liu-jun-zi-tang by the weight of 9g+3g+3g/day
-
Taoyuan, TaiwanChang Gung Memorial Hospital
Feb 5, 2021
High-risk cSCC Treated With Surgery and Radiotherapy
Not yet recruiting
- Squamous Cell Carcinoma of the Skin
- Peripheral blood sampling in order to evaluate changes in the circulating immune population
- (no location specified)
Feb 15, 2022
Immune Suppression Trial in Mansourah (Total intravenous anesthesia group, Total intravenous plus block group)
Completed
- Immune Suppression
- Total intravenous anesthesia group
- Total intravenous plus block group
-
Mansourah, Dakahlia, EgyptMansoura University Hospital
Sep 16, 2020
Metastatic Melanoma Naive to Immune Therapy in Metastatic Setting Trial in Lausanne (Pembrolizumab, Pembrolizumab - additional
Active, not recruiting
- Metastatic Melanoma Naive to Immune Therapy in Metastatic Setting
- Pembrolizumab
- Pembrolizumab - additional treatment
-
Lausanne, SwitzerlandOlivier Michielin
Jan 17, 2022
Colorectal Cancer Stage IV Trial in Sherbrooke (Resting state (Control), Moderate Intensity Continuous Exercise (MICE), High
Recruiting
- Colorectal Cancer Stage IV
- Resting state (Control)
- +2 more
-
Sherbrooke, Quebec, CanadaResearch Centre on Aging
May 16, 2022
Hepatocellular Carcinoma, Secondary Malignant Tumor of Liver Trial in Minneapolis (Yttrium-90)
Recruiting
- Hepatocellular Carcinoma
- Secondary Malignant Neoplasm of Liver
- Yttrium-90
-
Minneapolis, MinnesotaUniversity of Minnesota
Oct 21, 2021
Non-Hodgkin's Lymphoma, Hodgkin's Lymphoma, Myeloid Leukemia Trial in Detroit (Dasatinib, laboratory biomarker analysis)
Terminated
- Non-Hodgkin's Lymphoma
- +5 more
- Dasatinib
- laboratory biomarker analysis
-
Detroit, MichiganBarbara Ann Karmanos Cancer Institute
Dec 14, 2020
Tumor Immunogenicity Modulation in Cervical Cancer
Recruiting
- Cervical Cancer
- Benign Tumor of Uterus
-
Shantou, Guangdong, ChinaCancer Hospital of Shantou University Medical College
Dec 27, 2021
Lung Cancer Trial in Montréal (Patients with a living donor, Patients with a UCB donor)
Active, not recruiting
- Lung Cancer
- Patients with a living donor
- Patients with a UCB donor
-
Montréal, Quebec, CanadaHopital Sacre-Coeur
Feb 14, 2021
COVID-19, Vaccine Reaction, Elderly Trial (Taking capsule containing probiotics or )
Not yet recruiting
- COVID-19
- +2 more
- Taking capsule containing probiotics or placebo
- (no location specified)
May 16, 2022
Acute on Chronic Liver Failure Trial in New Delhi (Albumin, Standard Medical Treatment)
Unknown status
- Acute on Chronic Liver Failure
- Albumin
- Standard Medical Treatment
-
New Delhi, Delhi, IndiaInstitute of Liver & Biliary Sciences
Apr 7, 2020
SARS-CoV-2 Infection Trial in Soria (glycophosphopeptical AM3, Placebo)
Recruiting
- SARS-CoV-2 Infection
- glycophosphopeptical AM3
- Placebo
-
Soria, SpainCentro de Salud "La Milagrosa" Soria Sur
Jul 29, 2021